MetaCap

CollPlant Biotechnologies Financial Ratios

NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD

3.13-0.08 (-2.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CollPlant Biotechnologies ratio analysis

CollPlant Biotechnologies earned a net margin of -484.6% in FY 2025, up from -3225.0% a year earlier. Gross margin was 64.8% compared with a median of 59.0% over the prior 8 years. Return on equity reached -188.9%, meaning CollPlant Biotechnologies generated -1.89 dollars of profit for every dollar of shareholders' equity.

Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

CollPlant Biotechnologies financial ratios (annual)

CollPlant Biotechnologies annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Gross margin64.8%-215.5%81.8%-33.8%87.2%51.1%18.9%66.9%89.6%
Operating margin-484.3%-3,349.7%-68.5%-5,718.1%0.4%-91.2%-329.2%-84.7%-1,286.6%
Net margin-484.6%-3,225.0%-64.0%-5,660.5%1.5%-94.1%-481.6%-124.6%-1,306.9%
Free cash flow margin-398.4%-2,830.3%-33.9%-5,007.4%6.9%-79.6%-310.4%-40.9%-1,100.0%
Return on equity (ROE)-188.9%-123.3%-24.8%-52.4%0.5%-129.0%-273.1%-115.3%-117.0%
Return on assets (ROA)-106.5%-88.8%-20.6%-44.8%0.5%-53.3%-103.8%-71.4%-74.8%
Debt / equity———0.010.010.000.02—0.39
Current ratio2.534.448.6210.2014.961.681.463.214.56
Revenue growth360.4%-95.3%3,565.2%-98.1%154.9%164.8%-53.8%982.9%—
EPS growth———-7,750.0%——-255.9%——

Related